Madrigal Pharmaceuticals, Inc. (MDGL) Qhia nqe hauv lub sijhawm
Tam sim no, koj tuaj yeem yuav Madrigal Pharmaceuticals, Inc. Tshuag ntawm tus nqi ntawm $ 593,77 ib feem. Txij li thaum pib ntawm hnub, MDGL tus nqi tau hloov los ntawm 2.3926952%.
Madrigal Pharmaceuticals, Inc. tus nqi Tshuag qhib ntawm $574,89. Thaum lub sijhawm sib tham, tus nqi siab tshaj plaws tau mus txog yog $ 594,11 thaum qhov qis tshaj yog $ 573,00 thiab hnub kaw tus nqi yog $ 579,89.
Yuav tsum koj yuav Madrigal Pharmaceuticals Tshuag - Cov Duab Tseem Ceeb
[stock_market_widget type = "leaderboard" template = "basic" cov cuab tam = "MDGL" realtime = "false" api = "yahoo-finance"]Tshaj li 52 lub lis piam dhau los, Madrigal Pharmaceuticals, Inc. tus nqi Tshuag tau nce mus txog qhov siab ntawm $ 605,00 thiab 52 lub lis piam qis ntawm $ 265,00.
[stock_market_widget type="gauge" template = "basic" cov cuab tam = "MDGL" low_high = "52_week_low_high" red_color = "#DB2828" yellow_color = "#FBBD08" green_color = "#21BA45" animation_duration = "0" api = "yahoo-nyiaj txiag"]Thaum lub sij hawm dhau los 5 hnub trading ntawm Madrigal Pharmaceuticals, Inc. (MDGL) tus nqi tau hloov zuj zus raws li hauv qab no:
[stock_market_widget type = "table-history" template = "zebra4" cov cuab tam = "MDGL" teb = "hnub, qhib, siab, qis, kaw, ntim" ntau yam = "5d" interval = "1d" pagination = "false" rows_per_page= "5" sort_direction = "asc" alignment = "asc" ftp =”Koj yuav tsum yuav Madrigal Pharmaceuticals, Inc. shares hauv lub Kaum Ob Hlis?
Tam sim no Madrigal Pharmaceuticals, Inc. tus nqi Tshuag yog $593,77 thiab them cov nyiaj faib ntawm ib feem! Lub Madrigal Pharmaceuticals, Inc. cov nyiaj tau paj tau paj yog % ib xyoos yog tias koj yuav Madrigal Pharmaceuticals, Inc. Tshuag ntawm tus nqi tam sim no.
[stock_market_widget type = "key-value-table-companies" template = "basic" cov cuab tam = "MDGL" fields = "logo_name, cim, kev lag luam, sector, website, xov tooj, neeg ua hauj lwm_count, lub teb chaws, full_address" api = "yahoo-nyiaj txiag"]Kuj tseem xav txog kev xaiv tus broker uas muaj qhov zoo ntawm kev muab kev ua tiav rau yuav cov stocks los ntawm thoob plaws lub ntiaj teb no! Qhov no yuav tso cai rau koj kom diversify koj cov ntaub ntawv tom qab.
Analyst Consensus and Price Target on Madrigal Pharmaceuticals, Inc. Tshuag
[stock_market_widget type= » list » template = » Basic » color = » # 000000″ cov cuab tam = » MDGL » teb = » logo_name_symbol, pom zoo_key, phiaj xwm_high_price,target_median_price,target_low_price,analyst_opinions » realtime = »Kev faib tawm qhia Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. tsis tam sim no faib cov nyiaj faib tawm. Yog li ntawd, nws tsis tuaj yeem tsim cov nyiaj tau los passive tam sim no. Qhov no txhais tau hais tias cov Tshuag no tsuas yog muab cov peev txheej tau txais txiaj ntsig yog tias tus nqi nce yav tom ntej thiab rov muag dua ntawm tus nqi siab dua tus nqi yuav khoom.
[stock_market_widget type= » list » template = » Basic » color = » # 000000″ cov cuab tam = » MDGL » teb = » logo_name_symbol, txiaj, ex_dividend_date, dividend_rate, dividend_yield, 5_year_avg_dividend_yield, annual_dividual_rate, » api = "yahoo-finance"]Cov tswv cuab ntawm Madrigal Pharmaceuticals, Inc.
Nov yog cov tswv cuab tam sim no ntawm Madrigal Pharmaceuticals, Inc.:
- Janus Henderson Investors US LLC - 12,21%
- Baker Bros. Advisors LP – 9,243%
- Baker Bros. Advisors LP – 9,243%
- Avoro Capital Advisor LLC - 9,124%
- Paulson & Co., Inc. – 8,329%
- Rebecca Taub – 8,190%
- Vanguard Fiduciary Trust Co. - 7,831%
- BlackRock Advisors LLC – 5,381%
- Paul Friedman - 4,299%
- T. Rowe Nqe International Ltd. - 3,769% yog
Cov neeg sib tw ntawm Madrigal Pharmaceuticals, Inc.
Txawm hais tias cov neeg sib tw ncaj qha yuav txawv raws li kev tshwj xeeb thiab thaj chaw, ntawm no yog qee lub tuam txhab uas tuaj yeem suav tias muaj peev xwm sib tw rau Madrigal Pharmaceuticals, Inc.:
- Gilead Sciences : Gilead tab tom txhim kho kev kho mob rau NASH, suav nrog cov tshuaj tiv thaiv kab mob steatohepatitis. (Yuav Gilead Sciences Tshuag)
- Kev cuam tshuam cov tshuaj lag luam : Intercept Pharmaceuticals yog koom nrog kev txhim kho ntawm obeticholic acid (OCA), uas yog cov tshuaj latest rau kev kho mob ntawm NASH.
- Genfit : Genfit kuj tau tsom mus rau kev txhim kho kev kho mob rau NASH, nrog elafibranor ua nws tus thawj coj siv tshuaj. (Yuav Genfit Tshuag)
- Allergan (AbbVie) : Allergan, lub tuam txhab tau txais los ntawm AbbVie, tab tom txhim kho kev kho mob rau NASH, suav nrog cenicriviroc. (Yuav AbbVie Tshuag)
- Viking Kev Kho Mob : Viking Therapeutics tshwj xeeb hauv kev tsim kho cov kab mob metabolic, suav nrog NASH.
Cov tuam txhab no sawv cev rau qee qhov kev sib tw hauv cov kab mob metabolic thiab NASH qhov chaw, kev hloov pauv sai sai nrog cov kev xav tau kev kho mob tseem ceeb. Kev sib tw yog khaus nyob rau hauv cov nqe lus ntawm kev tsim cov kev kho mob zoo, ua tiav hauv kev sim tshuaj thiab tau txais kev pom zoo ntawm kev tswj hwm. Rau Madrigal Pharmaceuticals, qhov kev sib tw tseem tshuav txhais tau tias txuas ntxiv mus rau kev txhim kho nws cov neeg sib tw tshuaj, resmetirom, thaum tsim kho cov txheej txheem kho tshiab thiab ua kom pom cov txiaj ntsig kho mob ntawm nws cov khoom muaj peev xwm.
Cov neeg siv khoom ntawm Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, raws li lub tuam txhab kho mob-theem biopharmaceutical, tsis ncaj qha muag cov khoom lossis kev pabcuam rau cov neeg siv khoom xws li lub tuam txhab cov khoom siv ib txwm muaj. Txawm li cas los xij, nyob rau hauv cov ntsiab lus ntawm kev lag luam tshuaj, Madrigal Pharmaceuticals 'cov neeg siv khoom' tuaj yeem suav tias yog nws cov neeg koom tes, xws li:
- Investors thiab Shareholders : Txawm hais tias cov tub ua lag luam tsis yog cov neeg siv khoom hauv kev xav ib txwm muaj, lawv yog qhov tseem ceeb hauv kev muab nyiaj txiag tsim nyog rau Madrigal los pab nyiaj rau nws cov kev tshawb fawb tshuaj thiab kev tsim kho.
- Cov neeg koom tes thiab cov koom tes kev kawm : Madrigal feem ntau koom tes nrog cov kws tshawb fawb thiab cov tsev kawm ntawv los ua cov kev sim tshuaj thiab tsim kho tshiab. Cov kev sib koom tes no yuav suav nrog kev tshawb fawb kev sib koom tes thiab daim ntawv tso cai pom zoo.
- Cov Neeg Saib Xyuas Kev Noj Qab Haus Huv thiab Cov Cai : Cov koom haum tswj hwm, xws li FDA hauv Tebchaws Meskas thiab EMA hauv Tebchaws Europe, yog "cov neeg siv khoom" tseem ceeb rau Madrigal Pharmaceuticals. Lub tuam txhab tab tom ua haujlwm nrog cov koom haum no kom tau txais kev pom zoo kev cai rau nws cov neeg siv tshuaj.
- Cov neeg mob thiab cov kws kho mob : Txawm hais tias Madrigal tseem tsis tau ua lag luam ib yam khoom, cov neeg mob thiab cov kws kho mob yuav tau txais txiaj ntsig ncaj qha los ntawm lub tuam txhab kev siv zog los tsim kho tshiab rau cov kab mob tsis sib xws xws li kab mob tsis muaj dej cawv fatty siab (NASH).
Cov piv txwv no tsis yog tag nrho, thiab Madrigal Pharmaceuticals, Inc. daim ntawv teev cov neeg siv khoom yuav txawv nyob ntawm nws cov tswv yim kev lag luam thiab cov phiaj xwm loj hlob.
Vim li cas Kev Lag Luam Hauv Madrigal Pharmaceuticals, Inc. Tshuag
Kev nqis peev hauv Madrigal Pharmaceuticals Tshuag tuaj yeem txiav txim siab rau ntau yam laj thawj:
- Kev cog lus Pipeline : Madrigal Pharmaceuticals yog tsom rau kev tsim kho tshiab los kho cov kab mob metabolic, tshwj xeeb tshaj yog cov kab mob uas tsis yog-alcoholic fatty siab (NASH) thiab kab mob plawv. Nws tus thawj coj siv tshuaj, resmetirom (MGL-3196), yog nyob rau hauv kev txhim kho siab heev rau cov kev qhia no, nrog cov txiaj ntsig tau zoo los ntawm kev sim tshuaj.
- Unmet Kho Mob Xav Tau : Cov kab mob uas tsis yog-alcoholic fatty siab (NASH) yog ib qho teeb meem kev noj qab haus huv thoob ntiaj teb, tshwj xeeb hauv cov teb chaws tsim kho. Tam sim no tsis muaj kev pom zoo tshwj xeeb rau kev kho mob rau tus kab mob no, uas muab Madrigal Pharmaceuticals nrog lub sijhawm tseem ceeb hauv kev ua lag luam yog tias nws txoj kev kho mob ua pov thawj zoo thiab nyab xeeb.
- Clinical Development Strategy : Madrigal muaj lub tswv yim zoo rau kev txhim kho nws cov neeg sib tw tshuaj, nrog rau kev sim tshuaj zoo thiab kev koom tes nrog cov kws tshaj lij thiab cov koom haum los txhawb nws txoj kev tshawb fawb.
- Valorization Muaj peev xwm : Raws li lub tuam txhab kho mob-theem biopharmaceutical, kev nqis peev hauv Madrigal Pharmaceuticals nqa cov txiaj ntsig tseem ceeb yog tias resmetirom tau txais kev pom zoo kev tswj hwm thiab ua tiav kev lag luam. Qhov no tuaj yeem tsim cov txiaj ntsig zoo rau cov tub ua lag luam uas nkag mus rau theem pib.
- Kev txawj ntse thiab kev coj noj coj ua : Madrigal Pharmaceuticals 'kev tswj hwm pab pawg thiab cov kws tshawb fawb muaj kev txawj ntse hauv thaj tsam ntawm cov kab mob metabolic, txhim kho kev ntseeg siab hauv lawv lub peev xwm los ua tiav kev kho mob thiab ua tiav cov txheej txheem tswj hwm.
Kev nqis peev hauv ib qho khoom lag luam tshwj xeeb xws li Madrigal Pharmaceuticals, Inc. yuav tsum muaj kev tshawb fawb ntau thiab kev nkag siab txog kev pheej hmoo thiab cov hauv kev cuam tshuam nrog lub tuam txhab tshwj xeeb.
Koj tuaj yeem nqis peev hauv MADRIGAL PHARMACEUTICALS shares ntawm NASDAQ Ntiaj Teb Kev Ua Lag Luam (Nasdaq Index).
